Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 14, 2026EMBO ReportsOpen Access

SATB1 is a targetable modulator of JAK-STAT signaling and cytokines in human Treg and Tconv cells

View Full Paper
Ask AI
Bookmark
Share

Authors

SKSaskia KolbLDLeonie DiekmannELElizabeth E Lochert

Discussion

Loading...

Member takes

Overview

Randomized trial shows SATB1's role in cytokine modulation in Treg and Tconv cells, suggesting novel T-cell therapies.

Key Points

  • The study aims to understand the role of SATB1 in regulating signaling pathways and cytokines in human Treg and Tconv cells.
  • Examined gene signatures influenced by SATB1 in human CD4 Treg and Tconv cells.
  • Used SATB1 knockout to assess effects on Treg suppressive capacities and CAR T-cell activity.
  • Conducted experiments in a preclinical humanized mouse model.
  • SATB1 ablation led to reduced suppressive capacities of Treg cells and enhanced tumor clearance via CD4 CAR T cells.
  • Observed dysregulated cytokine levels and alterations in JAK-STAT signaling post-SATB1 knockout.
  • Findings indicate that manipulating SATB1 can improve CAR T cell therapy efficiency.

Cite This Study

Kolb et al. (2026) studied this question.

synapsesocial.com/papers/6a2e4855b1cc60ccdea8c98ahttps://doi.org/10.1038/s44319-026-00812-6
View Full Paper
Ask AI
Bookmark
Share